Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment

Moniek C.M. de Goeij,Madieke Liem,Dinanda J. de Jager,Nora Voormolen,Yvo W.J. Sijpkens,Joris I. Rotmans,Elisabeth W. Boeschoten,Friedo W. Dekker,Diana C. Grootendorst,Nynke Halbesma

Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment

2012

Moniek C.M. de Goeij
Madieke Liem
Dinanda J. de Jager
Nora Voormolen
Yvo W.J. Sijpkens
Joris I. Rotmans
Elisabeth W. Boeschoten
Friedo W. Dekker
Diana C. Grootendorst
Nynke Halbesma

Background/Aims: Proteinuria is a risk marker for progression of chronic kidney disease (CKD) and treatment with an angiotensin-converting enzyme inhibitor/angiot

Keywords:

Renal replacement therapy
Diabetes mellitus
Intensive care medicine
Proteinuria
Medicine
Angiotensin receptor
Angiotensin-converting enzyme
Kidney disease
Enzyme inhibitor
Endocrinology
Internal medicine
Nephrology
Urology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations